Ignite Creation Date:
2025-12-25 @ 4:22 AM
Ignite Modification Date:
2025-12-26 @ 3:25 AM
Study NCT ID:
NCT06275620
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-10-30
First Post:
2024-02-16
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN)
Sponsor:
Beacon Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-14
Start Date Type:
ACTUAL
Primary Completion Date:
2025-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-12
Completion Date Type:
ESTIMATED
First Submit Date:
2024-02-16
First Submit QC Date:
None
Study First Post Date:
2024-02-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-28
Last Update Post Date:
2024-10-30
Last Update Post Date Type:
ACTUAL